
Currently out of the existing stock ratings of Steve Beuchaw, 54 are a HOLD (39.42%), 30 are a SELL (21.9%), 53 are a BUY (38.69%).
Analyst Steve Beuchaw, has had 72.55% of price targets met with an average potential upside of 18.5%, reached in 293 days on average. Previously, Steve Beuchaw worked at MORGAN STANLEY, WOLFE.
Steve Beuchaw has documented 258 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 04-Aug-2024.
Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) on 10/9/2018. The price target of $320 was fulfilled within 1 day with a profit of $20.97 (6.15%), with a performance score of 61.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Oct-2025
$175
$6.68 (3.97%)
$188
21 days ago
(29-Oct-2026)
25/38 (65.79%)
$21.29 (13.85%)
134
Buy Since 25-Mar-2025
$200
$31.68 (18.82%)
$200
28 days ago
(22-Oct-2026)
11/17 (64.71%)
$44.49 (28.61%)
180
Buy Since 01-May-2025
$205
$36.68 (21.79%)
$235
29 days ago
(21-Oct-2026)
17/57 (29.82%)
$53.63 (35.43%)
95
Buy Since 18-Oct-2017
$162
$-6.32 (-3.75%)
$250
1 months 4 days ago
(15-Oct-2026)
21/30 (70%)
$12.66 (8.48%)
97
Buy Since 17-Oct-2025
$215
$46.68 (27.73%)
$172
1 months 5 days ago
(14-Oct-2026)
3/5 (60%)
$70.56 (48.85%)
40